Lipid modification

Summary

This guideline covers:

• Adults at higher risk of heart disease, stroke or peripheral arterial disease (cardiovascular disease). Risk of cardiovascular disease increases with age, as well as in people who smoke or who have high blood pressure or high cholesterol. People with heart disease in the family or men with a South Asian (for example, Indian, Pakistani or Bangladeshi) background are also at higher risk.
• People who have already had a heart attack, stroke or 'mini-stroke' (transient ischaemic attack or TIA).
• People who have angina or some other forms of cardiovascular disease.

The guideline doesn't cover everyone who is at increased risk of cardiovascular disease. This guideline does not include people with diabetes, those with major genetic causes of high cholesterol (familial hypercholesterolaemia) or people with chronic kidney disease, who are also at higher risk.

Documents

For healthcare professionals

• CG67 Lipid modification: NICE guideline
• CG67 Lipid modification: NICE guideline (MS Word format)
• CG67 Lipid modification: full guideline
• CG67 Lipid modification: full guideline (MS Word format)
• CG67 Lipid modification: guideline appendices A-C
• CG67 Lipid modification: guideline appendix D
• CG67 Lipid modification: guideline appendices E-J
• CG67 Lipid modification: guideline appendix K
• CG67 Lipid modification: guideline appendix L
• CG67 Lipid modification: quick reference guide

For patients, carers and the public

• CG67 Lipid modification: understanding NICE guidance
• CG67 Lipid modification: understanding NICE guidance (MS Word format)

Background information

• 2008/032 New NICE guidance on lowering cholesterol for people at high risk of cardiovascular disease

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

• Lipid modification: audit support
• Lipid modification: slide set
• Lipid modification: costing template
• Lipid modification: costing report